Aug 7, 2025 06:08AM Artiva Biotherapeutics, Inc. (ARTV) Reports Q2 Loss of $0.87

Jun 11, 2025 06:42AM H.C. Wainwright Assumes Artiva Biotherapeutics (ARTV) at Buy

May 13, 2025 04:05PM Artiva Biotherapeutics (ARTV) Announces Longer-term Phase 1/2 Data Demonstrating Prolonged Durability for AlloNK in Combination with Rituximab

May 8, 2025 05:06PM Artiva Biotherapeutics, Inc. (ARTV) Reports Q1 Loss of $0.83

Apr 8, 2025 04:05PM Artiva Biotherapeutics (ARTV) Appoints Subhashis Banerjee as Chief Medical Officer

Mar 26, 2025 06:52AM H.C. Wainwright Reiterates Buy Rating on Artiva Biotherapeutics (ARTV)

Mar 25, 2025 06:53AM Artiva Biotherapeutics (ARTV) PT Lowered to $20 at Cantor Fitzgerald

Jan 29, 2025 04:09PM Artiva Biotherapeutics (ARTV) Appoints Dan Baker to its Board

Dec 30, 2024 06:34AM H.C. Wainwright Starts Artiva Biotherapeutics (ARTV) at Buy

Oct 22, 2024 04:06PM Artiva Biotherapeutics (ARTV) Appoints Alison Moore to its Board

Sep 3, 2024 07:27AM TD Cowen Reiterates Buy Rating on Artiva Biotherapeutics (ARTV)

Aug 13, 2024 06:38AM Wedbush Starts Artiva Biotherapeutics (ARTV) at Outperform

Aug 13, 2024 06:32AM Cantor Fitzgerald Starts Artiva Biotherapeutics (ARTV) at Overweight

Aug 13, 2024 06:14AM TD Cowen Starts Artiva Biotherapeutics (ARTV) at Buy

Aug 13, 2024 03:02AM Jefferies Starts Artiva Biotherapeutics (ARTV) at Buy

Jul 19, 2024 01:05PM Artiva Biotherapeutics (ARTV) IPO opens at $16, priced at $12

Jul 19, 2024 05:54AM Artiva Biotherapeutics (ARTV) Prices 13.92M Share IPO at $12/sh

Jun 28, 2024 04:08PM Artiva (ARTV) Files for Proposed IPO